Phase 1 Clinical Trial of Percutaneous Cryoablation for Painful Musculoskeletal Tumor
Phase 1
- Conditions
- Painful Muscloskeletal tumor (osteoid osteoma, metastatic MSK tumor)
- Registration Number
- JPRN-UMIN000027828
- Lead Sponsor
- Gunma University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
1) Association between tumor and pain is unclear 2) There was a major neurovascular structure in and around the needle access or the planned ablation area 3) Tumor could not be detected by MRI or CT 4) Bleeding tendency and coagulation disorder were observed clinically. 5) Difficult to stop anti-coagulant drug 6) Active infection and inflammatory disease 7) Over 38 degree fever 8) Patients were confirmed or suspected to be pregnant 9) Attending physician judged the patient was not appropriate for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety (Within 1 month after the treatment)
- Secondary Outcome Measures
Name Time Method Frequency and degree of the adverse event, Short-term efficacy